Sergio Llorente-Ruiz - Publications

Multicenter study correlating molecular characteristics and clinical outcomes of cancer cases with patient-derived organoids.

Journal: Journal of experimental & clinical cancer research : CR

Published: February 12, 2025

Treatment Efficacy and Molecular Dynamics of Neoadjuvant Durvalumab and Olaparib in Resectable Urothelial Bladder Cancer: The NEODURVARIB Trial.

Journal: Clinical cancer research : an official journal of the American Association for Cancer Research

Published: September 18, 2024

Prospective study of the real impact of fusion centered genomic assays in patient management in a national collaborative group: the GETHI-XX-16 study.

Journal: Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico

Published: July 24, 2024

Proteomic profiles of peritoneal fluid-derived small extracellular vesicles correlate with patient outcome in ovarian cancer.

Journal: The Journal of clinical investigation

Published: October 04, 2023

Randomized phase II clinical trial of ruxolitinib plus simvastatin in COVID19 clinical outcome and cytokine evolution.

Journal: Frontiers in immunology

Published: February 01, 2023

MEK inhibitor sensitivity in BRAF fusion-driven prostate cancer.

Journal: Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico

Published: June 13, 2022